BOSTON, Mass. – May 23, 2012 – On Monday, May 21, 2012 the United States Preventive Services Task Force (USPSTF) issued their final recommendation on the PSA prostate cancer screening test, recommending against routine PSA exams for men of any age. In light of this recommendation, Health Dialog made our decision aid on prostate cancer testing publicly available, as we realize that men and their families will have lots of questions about the procedure and their options.
Health Dialog is a long-standing and leading provider of healthcare decision support programs, including award-winning patient decision aids. For more than 15 years we have been developing tools to help patients better understand the conditions that they face, and become informed about the various treatment and screening options they can choose from, including the different tradeoffs of each treatment option. Our Shared Decision Making® library of decision aids is available across a variety of conditions, including chronic disease, surgical decisions, testing and screening, and wellness.
You may access “Is a PSA Test Right for You?” at the link below. Please note, this decision aid should not replace consultation with a physician but rather should supplement physician care.
Access “Is a PSA Test Right for You”
About Health Dialog Services Corporation:
Health Dialog Services Corporation is a leading provider of healthcare analytics and decision support. The firm is a private, wholly-owned subsidiary of Bupa, a global provider of healthcare services. Health Dialog helps healthcare payors improve healthcare quality while reducing overall costs. Company offerings include health coaching for medical decisions, chronic conditions, and wellness; population analytic solutions; and consulting services. Health Dialog helps individuals participate in their own healthcare decisions, develop more effective relationships with their physicians, and live healthier, happier lives. For more information please visit www.healthdialog.com.